Gapping up
In reaction to strong earnings/guidance:
- WAB +7.6%, PFGC +2.2%, STWD +1.8%
M&A news:
- STML +148.4% (to be acquired by the Menarini Group in a transaction valued up to $677 million)
- KLXE +37% (KLX Energy Services and Quintana Energy Services (QES) to combine in an all-stock merger); QES +15.7%
Other news:
- APDN +43.6% (Applied DNA Sciences and Takis Biotech reports the production of neutralizing antibodies against SARS-CoV-2 after DNA vaccination in animals)
- CODX +8% (Logix Smart Coronavirus COVID-19 Test has been approved for sale in Mexico by the Mexican Department of Epidemiology)
- MNK +6.3% (announces positive findings in INOmax (Nitric Oxide) gas, for inhalation phase 4 observational registry in neonates with pulmonary hypertension; ends trial early)
- VIR +4% (Alnylam Pharma and Vir Biotechnology (VIR) announce the selection of a development candidate (DC) for VIR-2703, an investigational RNAi therapeutic targeting the SARS-CoV-2 genome)
- VXX +2.7% (rising with futures trading lower)
- MRNS +2.5% (provided an update on its clinical development activities and reported its financial results for the first quarter ended March 31, 2020)
- ALNY +1.6% (Alnylam Pharma and Vir Biotechnology (VIR) announce the selection of a development candidate (DC) for VIR-2703, an investigational RNAi therapeutic targeting the SARS-CoV-2 genome)
- GILD +0.7% (confirms that the FDA has granted EUA for remdesivir to treat COVID-19)
Analyst comments:
- LBTYA +0.8% (upgraded to Neutral from Underperform at Exane BNP Paribas)